5. Fever with Organ Dysfunction

Quick Recap

Undifferentiated ICU Syndromes, Protocol 5/6. This is the entry-point framework for the febrile patient with evolving organ dysfunction before a specific source is established. See the Sepsis/Septic Shock protocol (Infectious Diseases System) for the full septic shock management framework, and the individual infection-specific protocols throughout this library for source-specific management once identified.

1. First Principle — Most Fevers Are Infectious, But Not All

Most ICU fevers result from infection, and appropriate antibiotic therapy should produce improvement within a few days. However, temperature >=38.3C (101F) can occur in the ABSENCE of infection — awareness of noninfectious causes helps avoid unnecessary antibiotics, diagnostic testing, and lost time chasing an infectious source that doesn't exist. Temperatures above 38.9C (102F) are UNCOMMON for noninfectious causes, with specific exceptions: hyperthermia (see the Heat Stroke protocol, this Environmental System), drugs, transfusion reactions, and hematologic malignancy — a very high fever should still raise infectious suspicion first, but these specific noninfectious causes remain live possibilities even at extreme temperatures.

2. Comprehensive Causes Table

This table's breadth mirrors the same lesson as the Undifferentiated Coma protocol's differential — fever with organ dysfunction is a final common presentation for a very wide range of processes, and systematic category screening outperforms pattern-matching, especially in a sedated/uncommunicative ICU patient.

3. Central (Hypothalamic) Fever — A Genuine Fever, Not Hyperthermia

Damage to the hypothalamus from trauma, tumor, hemorrhage, or ischemia can raise the hypothalamic temperature SET POINT, causing a TRUE fever (as opposed to the failure-of-heat-dissipation mechanism of hyperthermia, see the Heat Stroke protocol). Clues suggesting central fever: a PLATEAU fever curve (rather than the typical spiking pattern of infection), POOR response to antipyretics, LACK OF SWEAT, and known/suspected hypothalamic injury. Important counterintuitive point: hypothalamic lesions are actually MORE COMMONLY associated with HYPOTHERMIA than fever — central fever, while a real entity worth recognizing, is the less common presentation of hypothalamic dysfunction.

4. Fever vs Hyperthermia — A Genuinely Important Mechanistic Distinction

Fever = an elevated temperature driven by an appropriately functioning hypothalamic set point being raised (typically by pyrogens, whether infectious or the noninfectious causes above).

Hyperthermia = elevated temperature DESPITE a normal hypothalamic set point, from increased heat production or decreased heat loss overwhelming normal thermoregulation — covers the hyperthermic syndromes (malignant hyperthermia, NMS, serotonin syndrome, heat stroke) and explains why these entities respond POORLY to antipyretics (which work by lowering the set point — irrelevant if the set point was never elevated in the first place) and instead require removal of the inciting agent PLUS targeted pharmacologic therapy and active cooling (see the Heat Stroke protocol, this system, for the full hyperthermic-syndrome differential and dantrolene/cyproheptadine/bromocriptine treatment detail).

5. Workup Sequence

Temperatures >=38.3C warrant a thorough history and physical exam to determine whether infection is the cause.

Initial minimum workup: two sets of blood cultures from two DIFFERENT sterile sites, chest radiograph (especially for intubated patients), urinalysis with microscopy. Additional cultures/testing ordered as clinically indicated based on the history/exam findings and the systematic category table above.

Decision to start antibiotics is based on: clinical stability, likelihood of infection, and immune status.

• Empiric broad-spectrum antimicrobial therapy should be started IMMEDIATELY for immunocompromised patients or those with sepsis/septic shock physiology while the workup proceeds (see Sepsis/Septic Shock and Febrile Neutropenia protocols)
• Stable patients WITHOUT an obvious infectious source may be monitored closely for fever recurrence and culture results BEFORE initiating antibiotics — a deliberate, evidence-based restraint against reflexive antibiotic initiation in a hemodynamically stable, non-immunocompromised patient with an unclear source, avoiding unnecessary antimicrobial exposure/resistance pressure

6. Immediate Stabilization (ABCDE)

Apply the full Sepsis/Septic Shock protocol (Infectious Diseases System) if hemodynamic instability accompanies the fever — this framework protocol's role is source identification and antibiotic-initiation decision-making, not to replace that protocol's resuscitation detail.

Checklist:

7. Treatment of Fever Itself

No clear benefit to treating LOW-GRADE fevers — and treatment can MASK characteristic disease-specific fever patterns (e.g., tertian/quartan fevers of malaria, Pel-Ebstein fever of lymphoma) that carry diagnostic value in themselves.

Lowering body temperature IS warranted for: high fevers associated with mental status changes or seizures, and in critically ill patients with severe underlying pulmonary or cardiovascular disease (where the metabolic demand of fever itself poses a real physiologic burden).

Antipyretics: acetaminophen preferred if no contraindications; NSAIDs as an alternative.

External cooling: cooling blankets, sponging, fans, ice baths.

Internal cooling (severe cases): gastric/peritoneal lavage, IV fluid replacement, hemodialysis, endovascular cooling catheter, sedation with paralysis if necessary.

Hyperthermic syndromes do NOT respond well to antipyretics — require inciting-agent removal and targeted pharmacotherapy (dantrolene for MH/NMS, bromocriptine for NMS, cyproheptadine for serotonin syndrome, physostigmine for anticholinergic syndrome) alongside active cooling — see the Heat Stroke protocol (this system) for full detail.

8. Investigations

Two blood cultures from separate sites, CXR, urinalysis with microscopy (minimum panel); additional testing per the systematic category screen — CBC with differential, procalcitonin, wound/line/CSF cultures as indicated, imaging per suspected source, LFTs (acalculous cholecystitis, drug reaction), TSH/cortisol (endocrine causes), autoimmune serologies if suggested by the clinical picture, drug/transfusion history review.

9. Organ Support

Source-specific treatment once identified per the relevant dedicated protocol; standard septic shock resuscitation if hemodynamically unstable; temperature management per Section 7; standard ICU supportive care.

10. Consultation Matrix

11. Monitoring Framework

Temperature trend/curve pattern (plateau vs spiking, diagnostic value), serial culture results, organ dysfunction trend (renal, hepatic, hemodynamic), response to any empiric antibiotics or antipyretics started.

12. Complications

Missed noninfectious cause from anchoring on infection, unnecessary antibiotic exposure/resistance pressure from reflexive treatment of low-grade or noninfectious fever, delayed sepsis recognition if antibiotics are inappropriately withheld in an unstable patient, missed hyperthermic syndrome treated ineffectively with antipyretics alone. Prevention: systematic infectious-AND-noninfectious category screening, appropriate antibiotic-initiation threshold based on stability/immune status, fever-vs-hyperthermia mechanistic distinction. Rescue: standard septic shock rescue therapy, targeted hyperthermic-syndrome pharmacotherapy, active cooling per Section 7.

13. Escalation & De-escalation

Escalate: hemodynamic instability accompanying fever -> full Sepsis/Septic Shock protocol; immunocompromised/neutropenic host -> immediate empiric antibiotics per the Febrile Neutropenia protocol.

De-escalate: source identified and treated, or fever resolved without an identified source in a stable patient -> standard monitoring, narrow/discontinue empiric antibiotics per culture data.

14. ICU Discharge Criteria

Source identified and treated (or fever resolved with a stable trajectory and no identified source in a stable patient), organ dysfunction stable or improving, antibiotics narrowed to a definitive course if infection confirmed, temperature trend normalized.

15. Documentation & Medicolegal Checklist

16. Key Guidelines

Abbott M, Byers DE. Temperature Alterations. Washington Manual of Critical Care, 4th ed, 2025 (Ch. 34). O'Grady NP, Barie PS, Bartlett JG, et al. Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med. 2008;36(4):1330-1349.

17. Controversies

The decision threshold for withholding empiric antibiotics in a stable, non-immunocompromised febrile patient without an obvious source involves genuine clinical judgment balancing antimicrobial stewardship against the risk of an evolving, not-yet-declared serious infection — practice varies by institutional culture and individual risk tolerance. The clinical value of fever pattern recognition (tertian/quartan, Pel-Ebstein) has diminished in the modern era of rapid diagnostic testing, but remains a genuinely useful adjunct when standard workup is unrevealing.

18. References

1. Abbott M, Byers DE. Temperature Alterations. Washington Manual of Critical Care, 4th ed, 2025 (Ch. 34).
2. O'Grady NP, Barie PS, Bartlett JG, et al. Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from ACCM and IDSA. Crit Care Med. 2008;36(4):1330-1349.
3. Niven DJ, Laupland KB. Pyrexia: aetiology in the ICU. Crit Care. 2016;20(1):247.

See also: Sepsis/Septic Shock, Necrotizing Fasciitis, Infective Endocarditis, Opportunistic Infections, Febrile Neutropenia (Infectious Diseases/Hematology Systems) for the infectious branch; Heat Stroke (Environmental System) for the hyperthermic syndrome differential and treatment; Adrenal Crisis, Thyroid Storm (Endocrine & Metabolic System) for the endocrine branch; HLH/MAS, CAPS (Autoimmune & Rheumatology System) for the autoimmune/hyperinflammatory branch.